News and Announcements
Phylogica Advancers Pfizer Collaboration, Achieves Research Milestone
- Published June 01, 2012 3:39PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
(MENAFN – ProactiveInvestors – Australia) Phylogica (ASX: PYC) has successfully achieved a research milestone under its collaboration and licence agreement with Pfizer to discover novel peptide-based vaccines.
The company completed the first stage of the collaboration with Pfizer in December last year, for which Phylogica will receive an undisclosed milestone payment.
—–
To view the full article, please click here.
To know more about Phylogica Limited, please click here.